Skip to main content

The Genetic Blueprint of Diabetes

Unlocking Pathways to Cure

  • 1st Edition - June 1, 2027
  • Latest edition
  • Editors: Meenakshi Dhanawat, Dilip Sharma
  • Language: English

The Genetic Blueprint of Diabetes: Unlocking Pathways to Cure is a comprehensive, advanced resource targeting biomedical researchers, clinicians, and graduate students focuse… Read more

Description

The Genetic Blueprint of Diabetes: Unlocking Pathways to Cure is a comprehensive, advanced resource targeting biomedical researchers, clinicians, and graduate students focused on the genetic and molecular basis of diabetes. It covers foundational genetics, epigenetics, gene-environment interactions, mitochondrial biology, and the gut microbiome, alongside translational topics like pharmacogenomics, gene therapy, and regenerative medicine. The book bridges basic science with clinical applications, emphasizing personalized and precision medicine approaches for both Type 1 and Type 2 diabetes. It also addresses ethical, societal, and diversity considerations in genetic interventions. Suitable for researchers, endocrinologists, pharmacologists, public health professionals, and advanced students, it fills a gap by integrating cutting-edge genomic research with therapeutic strategies and policy implications. The text’s disease-specific focus, comprehensive scope, translational orientation, and inclusion of future therapies distinguish it from general genetics or fragmented online resources, making it an essential guide for advancing diabetes diagnosis, treatment, and prevention.

Key features

  • Integrates genetics, epigenetics, environment, immunology, and emerging therapies in resource focused specifically on diabetes
  • Addresses ethical, policy, and equity issues related to genetic interventions
  • Applies practical applications of cutting-edge technologies to patient care

Readership

Professionals and scholars within the biomedical, clinical, and genetic research communities who are engaged with the pathophysiology, diagnosis, and treatment of diabetes; Endocrinologists

Table of contents

1. The Genetic Landscape of Diabetes: An Overview

2. Epigenetics and Diabetes: Beyond the DNA Code

3. Gene-Environment Interactions in Diabetes Susceptibility

4. Beta-Cell Biology and Genetic Regulation in Diabetes

5. Autoimmunity in Type 1 Diabetes: Genetic Triggers and Immune Pathways

6. Insulin Resistance: Genetic Underpinnings in Type 2 Diabetes

7. Mitochondrial Genetics and Metabolic Dysfunction in Diabetes

8. The Role of the Gut Microbiome and Metagenome in Diabetes

9. Pharmacogenomics in Diabetes: Toward Personalized Medicine

10. Gene Therapy and Genome Editing in Diabetes: Current Advances

11. Regenerative Medicine and Beta-Cell Replacement Therapy

12. Biomarkers and Predictive Genetics for Early Detection

13. From Blueprint to Cure: Ethical and Clinical Perspectives on Genetic Interventions

Product details

  • Edition: 1
  • Latest edition
  • Published: June 1, 2027
  • Language: English

About the editors

Meenakshi Dhanawat

Editor

Meenakshi Dhanawat is Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, India. Her research spans medicinal chemistry, synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction, with a particular focus on central nervous system drug delivery. She is a recipient of the Rajiv Gandhi National Fellowship.

Affiliations and expertise
Associate Professor, Amity Institute of Pharmacy, Amity University, Haryana, India

Dilip Sharma

Editor

Dilip Sharma is a pharmacologist whose research spans neuroscience, molecular biology, and translational medicine. He is currently Assistant Professor in the Amity Institute of Pharmacy, India. Prior to this, he completed postdoctoral training in Anesthesiology at Rutgers New Jersey Medical School, where he developed rodent models of diabetic and chemotherapy-induced neuropathic pain. His earlier work investigated Rho-kinase-inhibitory GLP-1 secretagogues for diabetic nephropathy. He serves as a reviewer and editorial board member for several journals.

Affiliations and expertise
Assistant Professor, Amity Institute of Pharmacy, Amity University, Haryana, India